Mood Dysregulation

Beyond the Bipolar Spectrum

Deborah A. Deliyannides

$112

Paperback

Not in-store but you can order this
How long will it take?

Availability Information

We source books from suppliers in Australia and overseas. For books we don't currently have in stock, the time it takes to get them from our suppliers can vary widely - from a few days to a few months - so we check each book with each supplier to determine the expected time it will take to be supplied to us.

We then advise you accordingly. If the time taken to get any book is too long for you, you can let us know and we will cancel or adjust your order, and refund as required.

To find out the anticipated arrival time for specific items prior to ordering, please contact us by phone or email:

Phone +61 2 9264 3111, or 1800 4 BOOKS (1800 4 26657) if outside Sydney:
option 1 Abbey's Bookshop (Crime, History, Science, Kids & more) • info@abbeys.com.au
option 2 Language Book Centre (ESL & Foreign Languages) • language@abbeys.com.au
option 3 Galaxy Bookshop (Sci-fi, Fantasy, Romance, Graphic Novels) • sf@galaxybooks.com.au

QTY:

English

Apple Academic Press Inc.
01 December 2023

Neurology & clinical neurophysiology; Psychiatry

"Reflecting the author’s vast clinical experience as a psychiatrist, this volume explains why so many people with treatment resistant depression respond to medication used to treat individuals with bipolar disorder. The book also helps to minimize the bipolar stigma by introducing the concept of ""mood dysregulation.""

At present, people with mood dysregulation are not adequately described on the pages of any diagnostic manual. A cardinal feature of mood dysregulation is dysphoria, a negative mood that is poorly understood but mistaken for the negative mood of depression, creating diagnostic confusion, one of the sources of treatment resistant depression. The author explains that a preponderance of the people she has seen in her practice who have so-called depression have mood disorders with features of bipolar disorder, including response to medications typically effective in people with bipolar disorders. Thus, these people are research orphans: to this day, a paucity of literature exists on this group of individuals. In this volume, the author addresses the clinical problems that result from failure to recognize such mood disorders.

Key features of the book:

Provides a thorough discussion of dysphoria that is not found in other books on the market Proposes a solution to a common and troublesome clinical problem, that of misidentified treatment resistant depression Helps to destigmatize the treatments that are most beneficial to those with dysphoria by introducing the concept of ""mood dysregulation"" Discusses the etiology of mood disorders with implications for prevention

This volume aims to help mental health professionals and patients more accurately recognize negative mood symptoms, dysphoria in particular, and arrive at more appropriate interventions to improve treatment outcomes for depression. No other book on the market takes up the topic of dysphoria and how its confusion with depression can lead to diagnostic mistakes that, in turn, lead to treatment failures and so-called treatment resistant depression."

By: Deborah A. Deliyannides
Imprint: Apple Academic Press Inc.
Country of Publication: Canada
Dimensions: Height: 229mm, Width: 152mm,
Weight: 480g
ISBN: 9781774912447
ISBN 10: 1774912449
Pages: 290
Publication Date: 01 December 2023
Audience: Professional and scholarly , Undergraduate
Format: Paperback
Publisher's Status: Active

1. HISTORICAL BACKGROUND 2. DSM MOOD DISORDERS 3. DIAGNOSTIC SYSTEMS 4. MOOD DYSREGULATION 5. CO-OCCURRING/RELATED CONDITIONS 6. BIOLOGY Brain 7. ETIOLOGY 8. TREATMENT 9. CLINICAL ILLUSTRATIONS

Deborah A. Deliyannides, MD, graduated from Jefferson Medical College, Philadelphia, PA, and completed her psychiatric residency at the New York Hospital-Cornell Medical Center in White Plains, NY. She is Assistant Clinical Professor of Psychiatry at Columbia University College of Physicians and Surgeons, New York, NY, and has been a research psychiatrist at the New York State Psychiatric Institute since 1990, where she treated a vast array of people with mood disorders. She was Medical Director of the Zucker Hillside Hospital Methadone Maintenance Treatment Program at the Long Island Jewish Medical Centre in Glen Oaks, NY, for over 10 years and earned added qualifications in addiction psychiatry. She is currently a psychoanalytic candidate at the NYU Post Doctoral Program for Psychotherapy and Psychoanalysis, and maintains private practices in Manhattan and in Darien, CT.